ask our doctors

Metastatic Disease

Get the facts on Metastatic Disease treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Metastatic Disease prevention, screening, research, statistics and other Metastatic Disease related topics. We answer all your qestions about Metastatic Disease.

Question: What is the treatment for metastatic disease, how do you get it and how long can u live with disease? I am 78yrs old. have no pain or sickness. I got real weak suddenly, was hospitalized because my potassium was low. feeling great. what should I do? dr. want to do exploratory brain surgery.

Answer: You are leaving out far too much information. How do you go from low potassium to exploratory brain surgery? There is little need to ever do exploratory surgery on the brain and it is never done for brain mets.


Metastatic Disease News

FDA Grants Genentech's Pertuzumab Priority Review

RTT News
The proposed indication is pertuzumab in combination with Herceptin and docetaxel chemotherapy for people with HER2-positive metastatic or locally recurrent, unresectable breast cancer, who have not received previous treatment or whose disease has ...
 

Expanded Palliative Care for All NSCLC Patients

Medscape
February 7, 2012 ? All patients with metastatic nonsmall-cell lung cancer should be offered palliative care, concurrent with standard cancer therapy, at the time of initial diagnosis, according to a provisional clinical opinion issued by the American ...
 

DigitalJournal.com (press release)

First and only treatment to extend survival for people with metastatic ...
DigitalJournal.com (press release)
 

USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt
MedPage Today
 

Cabozantinib Shows Encouraging Activity in Advanced Renal Cell Carcinoma

Drug Discovery & Development
The RCC patients had histologically confirmed RCC (with clear cell components) and metastases, were refractory to or had progressed following standard therapy, and had measurable disease per Response Evaluation Criteria In Solid Tumors (RECIST) Bone ...
 

FDA approves Novartis Gleevac for extended use in GIST patients

HealthJockey.com
Although originally approved in the metastatic disease setting, this subsequent trial has demonstrated that longer use of Gleevec can prolong patient's lives in earlier disease settings,? commented Richard Pazdur, MD, director of the Office of ...
 

Telegraph.co.uk

The final frontier in the war on cancer
Telegraph.co.uk
 

Results Support Planned, Randomized Phase 3 ADAPT Study-

MarketWatch (press release)
4, 2012 /PRNewswire via COMTEX/ -- Argos Therapeutics Inc. today announced that updated results from an open label Phase 2 study of its Arcelis(TM) immunotherapy, AGS-003, in combination with sunitinib in patients with unfavorable risk, metastatic ...
 

Health Newstrack

FDA Okays First Drug for Basal Cell Cancer
MedPage Today
 

Outcome Magazine

Metastatic Prostate Cancer Often Untreated
MedPage Today